Donoghue Forlines’s West Pharmaceutical WST Stock Holding History

Donoghue Forlines’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.27M	Buy	+9,114	New	+$2.79M	0.85%	36
2020 Q4	–	Sell	-5,007	Closed	-$1.38M	–	303
2020 Q3	$1.38M	Buy	+5,007	New	+$1.33M	0.38%	53
2020 Q1	–	Sell	-3,171	Closed	-$477K	–	143
2019 Q4	$477K	Sell	3,171 -17,385	-85%	-$2.53M	0.07%	135
2019 Q3	$2.92M	Buy	20,556 +15,214	+285%	+$2.09M	0.41%	71
2019 Q2	$669K	Sell	5,342 -4,400	-45%	-$519K	0.08%	129
2019 Q1	$1.07M	Buy	+9,742	New	+$1.01M	0.11%	75
2018 Q4	–	Sell	-8,329	Closed	-$1.03M	–	158
2018 Q3	$1.03M	Buy	8,329 +3,335	+67%	+$374K	0.08%	122
2018 Q2	$496K	Buy	+4,994	New	+$460K	0.04%	107

Other funds holding WST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Donoghue Forlines's WST Position: Q2 2026 in Review

Donoghue Forlines opened a new position in West Pharmaceutical (WST) in Q2 2026: 9,114 shares worth $3.27M. The stake represents 0.85% of the portfolio and ranks #36 among its holdings. This is a return to the name: Donoghue Forlines previously reported a position in WST as recently as Q3 2020.

Donoghue Forlines first reported a position in WST in Q2 2018 and has held it in 8 quarters since. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

Donoghue Forlines held 9,114 shares of West Pharmaceutical worth $3.27M as of Q2 2026.
West Pharmaceutical was a new Donoghue Forlines position in Q2 2026.
West Pharmaceutical made up 0.85% of Donoghue Forlines's portfolio in Q2 2026, its #36 holding.
Donoghue Forlines first reported a position in West Pharmaceutical in Q2 2018 and has held it in 8 quarters since.
831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Donoghue Forlines's 13F filing for Q2 2026, filed 7 Aug 2026.